353 related articles for article (PubMed ID: 20459390)
1. Development of novel cardiovascular therapeutics from small regulatory RNA molecules--an outline of key requirements.
Poller W; Fechner H
Curr Pharm Des; 2010; 16(20):2252-68. PubMed ID: 20459390
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure.
Poller W; Hajjar R; Schultheiss HP; Fechner H
Cardiovasc Res; 2010 Jun; 86(3):353-64. PubMed ID: 20176815
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular RNA interference therapy: the broadening tool and target spectrum.
Poller W; Tank J; Skurk C; Gast M
Circ Res; 2013 Aug; 113(5):588-602. PubMed ID: 23948584
[TBL] [Abstract][Full Text] [Related]
4. Small Interfering RNAs and RNA Therapeutics in Cardiovascular Diseases.
Bansal P; Arora M
Adv Exp Med Biol; 2020; 1229():369-381. PubMed ID: 32285425
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
[TBL] [Abstract][Full Text] [Related]
6. RNA interference as a gene-specific approach for molecular medicine.
Grünweller A; Hartmann RK
Curr Med Chem; 2005; 12(26):3143-61. PubMed ID: 16375707
[TBL] [Abstract][Full Text] [Related]
7. Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics.
Akhtari J; Tafazoli A; Mehrad-Majd H; Mahrooz A
Curr Clin Pharmacol; 2018; 13(3):173-182. PubMed ID: 29992895
[TBL] [Abstract][Full Text] [Related]
8. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.
Traber GM; Yu AM
J Pharmacol Exp Ther; 2023 Jan; 384(1):133-154. PubMed ID: 35680378
[TBL] [Abstract][Full Text] [Related]
9. microRNAs in cardiovascular diseases: current knowledge and the road ahead.
Condorelli G; Latronico MV; Cavarretta E
J Am Coll Cardiol; 2014 Jun; 63(21):2177-87. PubMed ID: 24583309
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.
Poller W; Dimmeler S; Heymans S; Zeller T; Haas J; Karakas M; Leistner DM; Jakob P; Nakagawa S; Blankenberg S; Engelhardt S; Thum T; Weber C; Meder B; Hajjar R; Landmesser U
Eur Heart J; 2018 Aug; 39(29):2704-2716. PubMed ID: 28430919
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.
Kwekkeboom RF; Lei Z; Doevendans PA; Musters RJ; Sluijter JP
Clin Sci (Lond); 2014 Sep; 127(6):351-65. PubMed ID: 24895056
[TBL] [Abstract][Full Text] [Related]
12. Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight.
Gorabi AM; Kiaie N; Aslani S; Jamialahmadi T; Johnston TP; Sahebkar A
J Autoimmun; 2020 Nov; 114():102529. PubMed ID: 32782117
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic advances in MicroRNA targeting.
Montgomery RL; van Rooij E
J Cardiovasc Pharmacol; 2011 Jan; 57(1):1-7. PubMed ID: 20729755
[TBL] [Abstract][Full Text] [Related]
14. RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.
Yu AM; Choi YH; Tu MJ
Pharmacol Rev; 2020 Oct; 72(4):862-898. PubMed ID: 32929000
[TBL] [Abstract][Full Text] [Related]
15. Small non-coding RNAs as novel therapeutics.
Rossbach M
Curr Mol Med; 2010 Jun; 10(4):361-8. PubMed ID: 20455856
[TBL] [Abstract][Full Text] [Related]
16. RNAi-based drug discovery and its application to therapeutics.
Hokaiwado N; Takeshita F; Banas A; Ochiya T
IDrugs; 2008 Apr; 11(4):274-8. PubMed ID: 18379962
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma.
Farra R; Grassi M; Grassi G; Dapas B
World J Gastroenterol; 2015 Aug; 21(30):8994-9001. PubMed ID: 26290628
[TBL] [Abstract][Full Text] [Related]
18. Small non-coding RNA therapeutics for cardiovascular disease.
Shah AM; Giacca M
Eur Heart J; 2022 Nov; 43(43):4548-4561. PubMed ID: 36106499
[TBL] [Abstract][Full Text] [Related]
19. RNA Therapeutics in Cardiovascular Disease.
Lucas T; Bonauer A; Dimmeler S
Circ Res; 2018 Jul; 123(2):205-220. PubMed ID: 29976688
[TBL] [Abstract][Full Text] [Related]
20. Exploring in vitro roles of siRNA in cardiovascular disease.
Tang Y; Ge YZ; Yin JQ
Acta Pharmacol Sin; 2007 Jan; 28(1):1-9. PubMed ID: 17184576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
